Fair Value Measurements (Tables)

3 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Schedule of Carrying Value and Estimated Fair Value of Liabilities Measured on a Recurring Basis

The following table sets forth the carrying value and the estimated fair value of the Company's financial instruments not measured at fair value in the Condensed Consolidated Balance Sheets:

	September 30, 2020				June 30, 2020
(In millions)	Carrying Value		Fair Value		Carrying Value		Fair Value
Broadcast rights payable	$	19.9	$	18.8	$	12.7	$	11.7
Total long-term debt	2,987.6		2,794.7		2,985.9		2,753.6

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following tables summarize recurring and nonrecurring fair value measurements at September 30, 2020 and June 30, 2020:

	September 30, 2020
(In millions)	Total		Level 1		Level 2		Level 3
Recurring fair value measurements
Cash and cash equivalents - cash equivalents	$	102.9	$	102.9	$	—	$	—
Accrued expenses
Contingent consideration	$	2.2	$	—	$	—	$	2.2
Deferred compensation plans	2.4		—		2.4		—
Other noncurrent liabilities
Contingent consideration	2.7		—		—		2.7
Deferred compensation plans	14.0		—		14.0		—
Total recurring liability fair value measurements	$	21.3	$	—	$	16.4	$	4.9

Schedule of Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis

		June 30, 2020
(In millions)		Total		Level 1		Level 2		Level 3		Total Losses
Recurring fair value measurements
Cash and cash equivalents - cash equivalents		$	115.2	$	115.2	$	—	$	—
Accrued expenses
Contingent consideration		$	1.3	$	—	$	—	$	1.3
Deferred compensation plans		3.4		—		3.4		—
Other noncurrent liabilities
Contingent consideration		3.6		—		—		3.6
Deferred compensation plans		13.5		—		13.5		—
Total recurring liability fair value measurements		$	21.8	$	—	$	16.9	$	4.9
Nonrecurring fair value measurements
Intangible assets, net 1		$	—	$	—	$	—	$	—	$	(5.2)
1	Represents the fair value of a national media trademark fully impaired at September 30, 2019. The impairment charge was recorded in the impairment of long-lived assets line on the Condensed Consolidated Statements of Earnings. For further discussion, refer to Note 4.